The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Incorporation of excess gadolinium into human bone from medical contrast agents
Abstract
We find anomalously high gadolinium (Gd) concentrations in the femoral head bones of patients exposed to chelated Gd, commonly used as a contrast agent for medical imaging. Gd is introduced in chelated form to protect patients from exposure to toxic free Gd(3+), a calcium antagonist which disrupts cellular processes. Recent studies suggest Gd chelates break down in vivo, and Gd accumulation in tissue is linked to medical conditions such as nephrogenic systemic fibrosis (NSF), acute kidney failure, and in some cases death. We measure Gd and other rare earth element (REE) concentrations in 35 femoral heads by solution based ICP-MS. Gd concentrations in patients with documented exposure to Gd-based contrast agents (n = 13: Gd DTPA-BMA (Omniscan) n = 6; Gd HP-DO3A (Prohance) n = 5; unknown type n = 4) are significantly higher (p < 0.001) than the control group (n = 17). We use our control group to establish the 'natural' background level of Gd in human bone (cortical 95% CI: 0.023, 0.041 nmol/g; trabecular 95% CI: 0.054, 0.107 nmol/g). A control group outlier reveals the occurrence of individuals with high concentrations of all REEs, including Gd. Because of this, we calculate Gd anomalies from the concentrations of adjacent REEs and normalize to the control group mean to isolate Gd input from contrast agents. Normalized Gd anomalies, (Gd/Gd*)(N), for exposed patients range up to >800 times the 'natural' level (95% CI: 124, 460). Our data confirm that Gd, introduced in chelated form, incorporates into bone and is retained for more than 8 years. No difference was observed in bone Gd concentrations and anomalies between patients dosed with Gd DTPA-BMA (Omniscan; n = 6) and Gd HP-DO3A (Prohance; n = 5). Osteoporotic fracture patients exposed to Gd have significantly lower Gd concentrations than osteoarthritis patients (p < 0.001). This indicates different mechanisms of metal incorporation and/or retention in osteoporotic bone tissues, and may signal an increased risk of endogenous Gd release for patients with increased rates of bone resorption (e.g. osteoporosis patients and menopausal, pregnant, and lactating women) who are exposed to Gd-based contrast agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Limit of detection. A closer look at the IUPAC definition
Long, G. L., & Winefordner, J. D. (1983) · Analytical Chemistry · doi:10.1021/ac00258a001 · Cited by 2,162
Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,859
Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M. B., Heaf, J. G., & Thomsen, H. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060601 · Cited by 1,400
Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent
Weinmann, H., Brasch, R., Press, W., & Wesbey, G. (1984) · American Journal of Roentgenology · doi:10.2214/ajr.142.3.619 · Cited by 1,231
Long, G. L., Voigtman, E. G., Kosinski, M. A., & Winefordner, J. D. (1983) · Analytical Chemistry · doi:10.1021/ac00259a060 · Cited by 1,120
Block of Stretch-Activated Ion Channels in Xenopus Oocytes by Gadolinium and Calcium Ions
Yang, X.-C., & Sachs, F. (1989) · Science · doi:10.1126/science.2466333 · Cited by 803
Anthropogenic origin of positive gadolinium anomalies in river waters
Bau, M., & Dulski, P. (1996) · Earth and Planetary Science Letters · doi:10.1016/0012-821x(96)00127-6 · Cited by 630
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I., & Kirk, G. A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1094 · Cited by 604
Incorporation and distribution of strontium in bone
Dahl, S. G., Allain, P., Marie, P. J., Mauras, Y., Boivin, G., Ammann, P., Tsouderos, Y., Delmas, P. D., & Christiansen, C. (2001) · Bone · doi:10.1016/s8756-3282(01)00419-7 · Cited by 590
Hamm, B., Staks, T., Mühler, A., Bollow, M., Taupitz, M., Frenzel, T., Wolf, K. J., Weinmann, H. J., & Lange, L. (1995) · Radiology · doi:10.1148/radiology.195.3.7754011 · Cited by 575
Mahaffey, K. R., Annest, J. L., Roberts, J., & Murphy, R. S. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209023071001 · Cited by 444
Laurent, S., Elst, L. V., & Muller, R. N. (2006) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.100 · Cited by 441
The relationship between thermodynamics and the toxicity of gadolinium complexes
Cacheris, W. P., Quay, S. C., & Rocklage, S. M. (1990) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(90)90055-7 · Cited by 436
Idée, J., Port, M., Raynal, I., Schaefer, M., Le Greneur, S., & Corot, C. (2006) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00447.x · Cited by 395
Eriksen, E. F., Hodgson, S. F., Eastell, R., DR. RIGGS, B. L., Cedel, S. L., & O'Fallon, W. M. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050402 · Cited by 366
Glimcher, M. J. (2006) · Reviews in Mineralogy and Geochemistry · doi:10.2138/rmg.2006.64.8 · Cited by 326
Pregnancy increases mobilization of lead from maternal skeleton
Gulson, B. L., Jameson, C. W., Mahaffey, K. R., Mizon, K. J., Korsch, M. J., & Vimpani, G. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90058-5 · Cited by 319
Bone and Tooth Mineralization: Why Apatite?
Pasteris, J. D., Wopenka, B., & Valsami-Jones, E. (2008) · Elements · doi:10.2113/gselements.4.2.97 · Cited by 297
Broome, D. R. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.02.011 · Cited by 283
Using gadolinium to identify stretch-activated channels: technical considerations
Caldwell, R. A., Clemo, H. F., & Baumgarten, C. M. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.2.c619 · Cited by 228
MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
Shellock, F. G., & Spinazzi, A. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.08.1038.1 · Cited by 221
Morcos, S. K. (2007) · The British Journal of Radiology · doi:10.1259/bjr/17111243 · Cited by 205
Case-control study of gadodiamide-related nephrogenic systemic fibrosis
Marckmann, P., Skov, L., Rossen, K., Heaf, J. G., & Thomsen, H. S. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm261 · Cited by 204
Gadolinium blocks low- and high-threshold calcium currents in pituitary cells
Biagi, B. A., & Enyeart, J. J. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.259.3.c515 · Cited by 183
Skinner, H. C. W. (2005) · Mineralogical Magazine · doi:10.1180/0026461056950275 · Cited by 177
Biomineralization: An Overview
Boskey, A. L. (2003) · Connective Tissue Research · doi:10.1080/03008200390152007 · Cited by 176
Physicochemical Properties of Gadoteridol and Other Magnetic Resonance Contrast Agents
Tweedle, M. F. (1992) · Investigative Radiology · doi:10.1097/00004424-199208001-00002 · Cited by 158
The safety of gadolinium in patients with stage 3 and 4 renal failure
Ergün, I., Keven, K., Uruç, I., Ekmekçi, Y., Canbakan, B., Erden, I., & Karatan, O. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi304 · Cited by 158
Carmouche, J. J., Puzas, J. E., Zhang, X., Tiyapatanaputi, P., Cory‐Slechta, D. A., Gelein, R. M., Zuscik, M. J., Rosier, R. N., Boyce, B. F., O’Keefe, R. J., et al. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7596 · Cited by 140
Changes in Serial Blood Lead Levels during Pregnancy
Rothenberg, S. J., Karchmer, S., Schnaas, L., Perroni, E., Zea, F., & Alba, J. F. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102876 · Cited by 129
Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis
Abraham, J. L., & Thakral, C. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.01.026 · Cited by 106
The effect of Pb2+ on the structure and hydroxyapatite binding properties of osteocalcin
Dowd, T. L., Rosen, J. F., Mints, L., & Gundberg, C. M. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00094-6 · Cited by 84
Preclinical Safety Evaluation of Gd-EOB-DTPA (Primovist)
Döhr, O., Hofmeister, R., Treher, M., & Schweinfurth, H. (2007) · Investigative Radiology · doi:10.1097/rli.0b013e318137a471 · Cited by 54
Thakral, C., & Abraham, J. L. (2007) · Journal of Electron Microscopy · doi:10.1093/jmicro/dfm020 · Cited by 54
Kay, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.102475 · Cited by 51
Osteoblasts and chondrocytes are important target cells for the toxic effects of lead.
Puzas, J. E., Sickel, M. J., & Felter, M. E. (1992) · PubMed · Cited by 44
Worldwide clinical safety assessment of gadoteridol injection: an update
Runge, V. M., & Parker, J. R. (1997) · European Radiology · doi:10.1007/pl00006900 · Cited by 42
Skeletal lead release during bone resorption: effect of bisphosphonate treatment in a pilot study.
Gulson, B. L., Mizon, K. J., Smith, H. C., Eisman, J. A., Palmer, J. M., Korsch, M. J., Donnelly, J., & Waite, K. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.021101017 · Cited by 30
Mineral Analysis Provides Insights into the Mechanism of Biomineralization
Boskey, A. L. (2003) · Calcified Tissue International · doi:10.1007/s00223-003-1002-8 · Cited by 27
Cited by
Intracranial gadolinium deposition after contrast-enhanced MR imaging
McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J. (2015) · Radiology · doi:10.1148/radiol.15150025 · Cited by 1,358
Kanda, T., Fukusato, T., Matsuda, M., Toyoda, K., Oba, H., Kotoku, J., Haruyama, T., Kitajima, K., & Furui, S. (2015) · Radiology · doi:10.1148/radiol.2015142690 · Cited by 874
Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms
Rogosnitzky, M., & Branch, S. (2016) · BioMetals · doi:10.1007/s10534-016-9931-7 · Cited by 766
Health effects and toxicity mechanisms of rare earth elements—Knowledge gaps and research prospects
Pagano, G., Guida, M., Tommasi, F., & Oral, R. (2015) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2015.01.030 · Cited by 590
Ding, Y., Wen, C., Hodgson, P., & Li, Y. (2014) · J. Mater. Chem. B · doi:10.1039/c3tb21746a · Cited by 531
Metadata
- Authors
- Darrah, T. H., Prutsman-Pfeiffer, J. J., Poreda, R. J., Ellen Campbell, M., Hauschka, P. V., & Hannigan, R. E.
- Venue
- Metallomics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009
- Volume
- 1
- Issue
- 6
- Pages
- 479
- ISSN
- 1756-5901 (ISSN-L)
- 1756-591X
- OpenAlex
- W2129768655
- Cited by
- 299
- References
- 39
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.